文献速递睡眠呼吸障碍咽喉与嗓音

上气道刺激治疗阻塞性睡眠呼吸暂停:48个月随访后的患者报告结局

Upper Airway Stimulation for Obstructive Sleep Apnea: Patient-Reported Outcomes after 48 Months of Follow-up.
PubMed 文献 · Otolaryngol Head Neck Surg · 2017-02-14

STAR试验为多中心前瞻性队列研究,126例中重度阻塞性睡眠呼吸暂停患者植入上气道刺激系统,48个月时91例完成随访。与基线相比,Epworth嗜睡量表(ESS)显著降低(P=.01),睡眠功能结局问卷(FOSQ)显著改善(P=.01),85%的床伴报告打鼾轻微或无打鼾。

要点

  • 48个月时ESS较基线显著降低(P=.01),日间嗜睡改善。
  • 48个月时FOSQ较基线显著改善(P=.01),睡眠相关生活质量提高。
  • 85%的床伴报告打鼾轻微或无打鼾;2例因导线故障需再次手术,无并发症。

核心结论

  • 在部分中重度阻塞性睡眠呼吸暂停患者中,上气道刺激对患者报告结局(ESS、FOSQ、打鼾)的获益在48个月时得以维持。

研究设计与样本

  • 多中心前瞻性队列研究(STAR试验),由产业支持的多中心学术与临床机构开展。
  • 126例参与者植入上气道刺激系统,48个月时91例完成随访。

主要发现

  • 48个月时ESS较基线显著降低(P=.01)。
  • 48个月时FOSQ较基线显著改善(P=.01)。
  • 85%的床伴报告打鼾轻微或无打鼾。
  • 2例因导线故障需再次手术,无并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective To assess patient-based outcomes of participants in a large cohort study-the STAR trial (Stimulation Therapy for Apnea Reduction)-48 months after implantation with an upper airway stimulation system for moderate to severe obstructive sleep apnea. Study Design A multicenter prospective cohort study. Setting Industry-supported multicenter academic and clinical setting. Subjects Participants (n = 91) at 48 months from a cohort of 126 implanted participants. Methods A total of 126 participants received an implanted upper airway stimulation system in a prospective phase III trial. Patient-reported outcomes at 48 months, including Epworth Sleepiness Scale (ESS), Functional Outcomes of Sleep Questionnaire (FOSQ), and snoring level, were compared with preimplantation baseline. Results A total of 91 subjects completed the 48-month visit. Daytime sleepiness as measured by ESS was significantly reduced ( P = .01), and sleep-related quality of life as measured by FOSQ significantly improved ( P = .01) when compared with baseline. Soft to no snoring was reported by 85% of bed partners. Two patients required additional surgery without complication for lead malfunction. Conclusion Upper airway stimulation maintained a sustained benefit on patient-reported outcomes (ESS, FOSQ, snoring) at 48 months in select patients with moderate to severe obstructive sleep apnea.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Gillespie MB, Soose RJ, Woodson BT, et al. Upper Airway Stimulation for Obstructive Sleep Apnea: Patient-Reported Outcomes after 48 Months of Follow-up. Otolaryngol Head Neck Surg. 2017. PMID: 28194999. doi:10.1177/0194599817691491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。